“…List of used experiment IDs for indicated tissue and primary cells: a) murine heart: MM-00170 (Muchir et al, 2007), MM-00253 (Dufour et al, 2007), MM-00257 (Zhao et al, 2007), MM-00262 (Alcendor et al, 2007), MM-00300 (Ramchandran et al, 2006), MM-00322, (Thorrez et al, 2008), MM-00330 (Lattin et al, 2008), MM-00368 (Barger et al, 2008), MM-00384 (Wong et al, 2010), MM-00476 (Abd Alla et al, 2016), MM-00485 (Oka et al, 2011), MM-00492 (Wang et al, 2016), MM-00497 (Shuai et al, 2011), MM-00507 (Shuai et al, 2011), MM-00561 (Ricard et al, 2010), MM-00834 (Traister et al, 2013), MM-00841 (Mercader et al, 2012), MM-01538 (Gambino et al, 2013), MM-01642 (Lucas et al, 2014), MM-01875 (Lucas et al, 2014); b) murine primary fibroblast (dermis): MM-00159 (Vallender and Lahn, 2006), MM-00180 (Vallender and Lahn, 2006), MM-00627 (Garinis et al, 2009), MM-00724 (Garinis et al, 2009); c) murine primary keratinocytes: MM-01215 (Allende et al, 2013); d) healthy human epidermis tissue (biopsy): HS-02924 (Esaki et al, 2015); e) human primary keratinocytes (untreated): HS-02625 (Yunoki et al, 2018), HS-02787 (Busch et al, 2008), HS-02490 (Swindell et al, 2012), HS-00220 (Sa et al, 2007); f) human primary keratinocytes (treated with TNFα, IFNα, IFNγ or IL4; 24 h): HS-02490 (Swindell et al, 2012); g) human primary keratinocytes (treated with 10 ng/ml I IFNγ; 96 h): HS-02625 (Yunoki et al, 2018); h) human primary fibroblasts (untreated): HS-00393, HS-00481 (Chen et al, 2008), HS-00805 (Verkerk et al, 2009), HS-00928 (Wang et al, 2012), HS-00963, HS-00989 (Strunnikova et al, 2009), HS-01109 (Visser et al, 2012), HS-01279 (Marchina et al, 2014), HS-01311 (Henrichsen et al, 2011), HS-01326 (Voets et al, 2012), HS-02421 (Smith et al, 2008); i) primary artery smooth muscle cells (heart): HS-00478 (Shalhoub et al, 2010); j) primary bronchial smooth muscle cells: HS-00039 (Bosse et al, 2007); k) healthy oesophagus squamous tissue (biopsy): HS-01298 (Wang et al, 2013), HS-00217, HS-00017 (Roth et al, 2006), HS-01525 (Sato et al, 2013); squamous cell carcinoma (grade G1): HS-01298 (Wang et al, 2013); oesophagus adenocarcinoma: HS-00002; HS-01298 (Wang et al, 2013); Barrett’s oesophagus (pre-malignant): HS-01298 (Wang et al, 2013); primary macrophages: HS-0...…”